Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Anti-inflammatory mechanism leads to development of oral medications for atherosclerosis, IBS

Research led by Charles Nichols, PhD, Associate Professor of Pharmacology at LSU Health Sciences Center New Orleans, describes a powerful new anti-inflammatory mechanism that could lead to the development of new oral medications for atherosclerosis and inflammatory bowel disorders (IBS).

7 Oct 2013

Researchers identify protein that triggers inflammation in patients with hemorrhage, sepsis

Investigators at The Feinstein Institute for Medical Research have discovered a protein in the human body that can trigger and mediate inflammation in patients suffering from hemorrhage and sepsis. The findings were published in the online version of Nature Medicine on October 6, 2013.

7 Oct 2013

AbbVie announces HUMIRA phase II study results for treating hidradenitis suppurativa

AbbVie (NYSE: ABBV) today announced results from a post-hoc analysis of an investigational Phase II study, which evaluated HUMIRA® (adalimumab) in the treatment of patients with moderate-to-severe hidradenitis suppurativa (HS) after 16 weeks of therapy.

7 Oct 2013

J&J's Janssen Companies Launch A Trio Of Collaborations

...

3 Oct 2013

New classification criteria for systemic sclerosis published in ACR journal

New classification criteria for systemic sclerosis have just been published and are more sensitive than the 1980 criteria, enabling earlier identification and treatment of this disabling autoimmune disease.

3 Oct 2013

Gout increases risk of heart attack and stroke

New research published in this month’s Rheumatology journal has found that having gout doubles the risk of heart attack and stroke. The research tracked the health of more than 205,000 gout patients using data spanning five decades to determine links between gout and heart attack and stroke.

3 Oct 2013

Data from Flexion Therapeutics' FX006 Phase 2b trial for OA to be presented at ACR/ARHP meeing

Flexion Therapeutics, Inc. announced today that new data from a Phase 2b dose-ranging trial of the company's lead compound, FX006, in osteoarthritis has been accepted for an oral presentation at the 2013 Annual Scientific Meeting of the American College of Rheumatology and the Association of Rheumatology Health Professionals.

2 Oct 2013

Servier Joins Xention To Develop AF Drug In Up To $163.2M Deal

...

2 Oct 2013

Canada should start screening 'Baby Boomers' for hepatitis C virus infection, say liver specialists

Canada should begin screening 'Baby Boomers' for the hepatitis C virus infection, since this age group is likely the largest group to have the illness, and most don't know they have it, say a group of liver specialists in the Toronto Western Hospital Francis Family Liver Clinic. Unlike many other chronic viral infections, early treatment makes hepatitis C curable.

1 Oct 2013

Roadmap of protein interactions may lead to new therapeutic approaches for type 2 diabetes

A team led by scientists at The Scripps Research Institute (TSRI) has created the first comprehensive roadmap of the protein interactions that enable cells in the pancreas to produce, store and secrete the hormone insulin.

1 Oct 2013

Central BP achieves the same with less

Using central, rather than brachial, blood pressure (BP) to guide treatment decisions results in patients with hypertension being given less medication, show results from a randomized trial.

30 Sep 2013

Pfizer Licenses Gliknik's Pooled IVIG In $25M+ Deal

...

30 Sep 2013

FDA approves Cimzia (certolizumab pegol) for active psoriatic arthritis

UCB announced today that the U.S. Food and Drug Administration has approved Cimzia (certolizumab pegol) for the treatment of adult patients with active psoriatic arthritis.

30 Sep 2013

Patients treated by ID physicians less likely to die in hospital

In a first-of-its-kind study to evaluate the impact of a medical specialty on patient outcomes, researchers found that hospitalized patients with severe infections such as meningitis and Clostridium difficile are significantly less likely to die if they receive care from an infectious diseases specialist. The study, which analyzed nearly 130,000 Medicare patient cases, is now available online and will be published in the December 15 issue of Clinical Infectious Diseases.

30 Sep 2013

Psoriasis and the nervous system: an interview with Dr Nicole Ward, Case Western Reserve University

The prevalence of skin disease exceeds that of obesity, hypertension or cancer. One in three individuals in the United States suffers with a skin disease, with ~2-3% of the American population suffering from psoriasis.

27 Sep 2013

Scientists discover critical regulator for directing pluripotent stem cells to make blood-forming stem cells

Stem cell scientists have moved one step closer to producing blood-forming stem cells in a Petri dish by identifying a key regulator controlling their formation in the early embryo, shows research published online today in Cell.

27 Sep 2013

Childhood abuse, lack of parental affection may increase health risk in adulthood

The effects of childhood abuse and lack of parental affection can last a lifetime, taking a toll both emotionally and physically.

27 Sep 2013

Scientists study genetic factors involved in complex diseases

Although heavily studied, the specific genetic causes of "complex diseases," a category of disorders which includes autism, diabetes and heart disease, are largely unknown due to byzantine genetic and environmental interactions.

27 Sep 2013

Continental Who's Who recognizes Thomas M. DeBerardino as Top Orthopedic Surgeon

Dr. Thomas M. DeBerardino, M.D. is recognized by Continental Who's Who as a Top Orthopedic Surgeon as a result of his vast success within the field of Sports Medicine. Dr. DeBerardino is an Associate Professor of Orthopedic Surgery with the University of Connecticut Health Center.

26 Sep 2013

$Repeating BMD tests after four years provides no clinical benefit of fracture risk in older adults$

Repeating BMD tests after four years provides no clinical benefit of fracture risk in older adults

Repeating bone mineral density (BMD) tests after four years provides little clinical benefit when assessing bone fracture risk in seniors age 75 and older, according to a recent study led by researchers at the Harvard Medical School-affiliated Institute for Aging Research at Hebrew SeniorLife. The study appears in the Sept. 25 online issue of JAMA.

25 Sep 2013

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Anti-inflammatory mechanism leads to development of oral medications for atherosclerosis, IBS

Researchers identify protein that triggers inflammation in patients with hemorrhage, sepsis

AbbVie announces HUMIRA phase II study results for treating hidradenitis suppurativa

J&J's Janssen Companies Launch A Trio Of Collaborations

New classification criteria for systemic sclerosis published in ACR journal

Gout increases risk of heart attack and stroke

Data from Flexion Therapeutics' FX006 Phase 2b trial for OA to be presented at ACR/ARHP meeing

Servier Joins Xention To Develop AF Drug In Up To $163.2M Deal

Canada should start screening 'Baby Boomers' for hepatitis C virus infection, say liver specialists

Roadmap of protein interactions may lead to new therapeutic approaches for type 2 diabetes

Central BP achieves the same with less

Pfizer Licenses Gliknik's Pooled IVIG In $25M+ Deal

FDA approves Cimzia (certolizumab pegol) for active psoriatic arthritis

Patients treated by ID physicians less likely to die in hospital

Psoriasis and the nervous system: an interview with Dr Nicole Ward, Case Western Reserve University

Scientists discover critical regulator for directing pluripotent stem cells to make blood-forming stem cells

Childhood abuse, lack of parental affection may increase health risk in adulthood

Scientists study genetic factors involved in complex diseases

Continental Who's Who recognizes Thomas M. DeBerardino as Top Orthopedic Surgeon

Repeating BMD tests after four years provides no clinical benefit of fracture risk in older adults

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Edoardo Fabini

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Edoardo Fabini

Newsletters you may be interested in